Naltrexone Alkylation Process Using N-Ethyl-2-Pyrrolidone
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing naltrexone lack efficiency and purity, particularly on an industrial scale, and there is a need for alternative processes that can yield highly pure naltrexone.
Innovation Solution
The process involves alkylation of noroxymorphone with cyclopropylmethyl halide in N-ethyl-2-pyrrolidone, using an acid scavenger, and controlling reaction kinetics to achieve high yield and purity of naltrexone, which can then be further processed to nalmefene via the Wittig reaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If direct alkylation of noroxymorphone with cyclopropylmethylbromide is performed using conventional methods, then naltrexone can be produced, but the purity and yield are insufficient for industrial application
Solution Approach 1:
The patent changes the reaction parameters by using a specific base (potassium carbonate or cesium carbonate) in a specific solvent (N-methyl-2-pyrrolidone or N-ethyl-2-pyrrolidone) at controlled temperatures (40-80°C), which optimizes both the purity and yield of naltrexone production
Solution Approach 2:
The patent introduces a specific base as an intermediary substance that facilitates the alkylation reaction between noroxymorphone and cyclopropylmethylbromide, enabling high-yield production while maintaining purity through controlled reaction mechanisms
2Reliability
If conventional alkylation methods are used, then the process can be performed, but the reaction kinetics are not controlled efficiently leading to impurities
Solution Approach 1:
The patent implements process monitoring and control where reaction progress is tracked and conditions are adjusted to maintain optimal kinetics, ensuring consistent production of pure naltrexone while managing reaction complexity through systematic control
3Productivity
If existing alkylation processes are applied, then naltrexone production is achieved, but the method is not readily applicable on industrial scale
Solution Approach 1:
The patent divides the manufacturing process into distinct, optimized stages with specific reagents and conditions for each step, making the overall complex process manageable and scalable for industrial production while maintaining simplicity in execution
Solution Approach 2:
The patent optimizes reaction parameters including solvent choice (N-methyl-2-pyrrolidone or N-ethyl-2-pyrrolidone), base selection (potassium carbonate or cesium carbonate), temperature range (40-80°C), and reaction time to achieve conditions that are both industrially scalable and operationally simple
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method consistently produces chemically pure naltrexone with controlled impurity levels, enabling direct use in nalmefene production and efficient removal of unreacted noroxymorphone, suitable for industrial application.
Implementation Method 1
The present invention relates to an improved process for producing naltrexone from noroxymorphone by alkylation of noroxymorphone with a cyclopropylmethyl halide in N-ethyl-2-pyrrolidone
Data Source
AI summary
The present invention relates to an improved process for producing naltrexone [17- (cyclopropylmethyl)-4,5a-epoxy-3,14-dihydroxy-morphinan-6-one] from noroxymorphone [4,5- a-epoxy-3,14-dihydroxy-morphinan-6-one] by alkylation with a cyclopropylmethyl halide.